Prot# AI424-075: The SABAR Study: Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study: Endothelial Function in HIV-Infected Subjects Switched to an Atazanavir Regimen

Project: Research project

Project Details

StatusFinished
Effective start/end date2/15/05 → 10/22/10

Funding

  • Bristol-Myers Squibb Company (AI424-075 / SABAR)